BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18040792)

  • 1. Combined and independent effects of chronic marijuana use and HIV on brain metabolites.
    Chang L; Cloak C; Yakupov R; Ernst T
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):65-76. PubMed ID: 18040792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.
    Keller MA; Venkatraman TN; Thomas A; Deveikis A; LoPresti C; Hayes J; Berman N; Walot I; Padilla S; Johnston-Jones J; Ernst T; Chang L
    Neurology; 2004 May; 62(10):1810-7. PubMed ID: 15159483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study.
    Prescot AP; Locatelli AE; Renshaw PF; Yurgelun-Todd DA
    Neuroimage; 2011 Jul; 57(1):69-75. PubMed ID: 21349338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults.
    Thames AD; Kuhn TP; Williamson TJ; Jones JD; Mahmood Z; Hammond A
    Drug Alcohol Depend; 2017 Jan; 170():120-127. PubMed ID: 27889592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use.
    Wang HA; Liang HJ; Ernst TM; Oishi K; Chang L
    J Neuroinflammation; 2020 Aug; 17(1):230. PubMed ID: 32758262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.
    Thames AD; Mahmood Z; Burggren AC; Karimian A; Kuhn TP
    AIDS Care; 2016; 28(5):628-32. PubMed ID: 26694807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
    Chang L; Ernst T; Speck O; Grob CS
    Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task.
    Meade CS; Bell RP; Towe SL; Chen NK; Hobkirk AL; Huettel SA
    Addict Biol; 2019 Nov; 24(6):1235-1244. PubMed ID: 30239074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
    Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
    Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aging on brain metabolism in antiretroviral-naive HIV patients.
    Ernst T; Chang L
    AIDS; 2004 Jan; 18 Suppl 1():S61-7. PubMed ID: 15075499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
    Taylor MJ; Schweinsburg BC; Alhassoon OM; Gongvatana A; Brown GG; Young-Casey C; Letendre SL; Grant I;
    J Neurovirol; 2007 Apr; 13(2):150-9. PubMed ID: 17505983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.
    Sung YH; Carey PD; Stein DJ; Ferrett HL; Spottiswoode BS; Renshaw PF; Yurgelun-Todd DA
    Behav Brain Res; 2013 Jun; 246():154-61. PubMed ID: 23466689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep gray matter structures in HIV infection: a proton MR spectroscopic study.
    Meyerhoff DJ; Weiner MW; Fein G
    AJNR Am J Neuroradiol; 1996 May; 17(5):973-8. PubMed ID: 8733976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
    Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
    AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.
    Laubenberger J; Häussinger D; Bayer S; Thielemann S; Schneider B; Mundinger A; Hennig J; Langer M
    Radiology; 1996 Jun; 199(3):805-10. PubMed ID: 8638009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.
    Paul RH; Yiannoutsos CT; Miller EN; Chang L; Marra CM; Schifitto G; Ernst T; Singer E; Richards T; Jarvik GJ; Price R; Meyerhoff DJ; Kolson D; Ellis RJ; Gonzalez G; Lenkinski RE; Cohen RA; Navia BA
    J Neuropsychiatry Clin Neurosci; 2007; 19(3):283-92. PubMed ID: 17827413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences.
    Wesley MJ; Hanlon CA; Porrino LJ
    Psychiatry Res; 2011 Jan; 191(1):51-9. PubMed ID: 21145211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.